Literature DB >> 3306242

Crigler-Najjar syndrome types I and II. Clinical experience--King's College Hospital 1972-1978. Phenobarbitone, phototherapy and liver transplantation.

S Pett, A P Mowat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3306242     DOI： 10.1016/0098-2997(87)90009-4

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN： 0098-2997


× No keyword cloud information.
  14 in total

1.  Orthotopic liver transplantation in liver-based metabolic disorders.

Authors:  A P Mowat
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

2.  Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.

Authors:  Kevin A Strauss; Charles E Ahlfors; Kyle Soltys; George V Mazareigos; Millie Young; Lauren E Bowser; Michael D Fox; James E Squires; Patrick McKiernan; Karlla W Brigatti; Erik G Puffenberger; Vincent J Carson; Hendrik J Vreman
Journal:  Hepatology       Date:  2020-02-05       Impact factor: 17.425

Review 3.  Present position of liver transplantation and its impact on hepatological practice.

Authors:  J G O'Grady; R Williams
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

4.  Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I.

Authors:  M Rela; P Muiesan; H Vilca-Melendez; A Dhawan; A Baker; G Mieli-Vergani; N D Heaton
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

5.  Crigler-Najjar syndrome type I: management with phototherapy crib mattress.

Authors:  R Hughes-Benzie; D A Uttley; H M Heick
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

6.  Treatment of Crigler-Najjar type II with small-dose phenobarbital.

Authors:  Z M Younossi; P Foroozan
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

7.  Reduction of hyperbilirubinemia with hypericum extract (St. John's Wort) in a patient with Crigler-Najjar syndrome type II.

Authors:  Oliver Kummer; Felix Hammann; Manuel Haschke; Stephan Krähenbühl
Journal:  Br J Clin Pharmacol       Date:  2016-03-07       Impact factor: 4.335

8.  Intrathecal baclofen therapy after liver transplant in a patient with Crigler-Najjar syndrome.

Authors:  Napala R Pratini; Jacob A Neufeld
Journal:  PM R       Date:  2013-12-21       Impact factor: 2.298

Review 9.  PharmGKB summary: very important pharmacogene information for UGT1A1.

Authors:  Julia M Barbarino; Cyrine E Haidar; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2014-03       Impact factor: 2.089

10.  Crigler Najjar Syndrome Type 2 (CNS Type 2): An Unwonted Cause of Jaundice in Adults.

Authors:  Prabhat Kumar; Gargi Sasmal; Shreya Gupta; Renu Saxena; Sudha Kohli
Journal:  J Clin Diagn Res       Date:  2017-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.